BloombergLean L·
Summit Therapeutics Jumps on $2 Billion AstraZeneca Deal
Summit Therapeutics Inc. shares rose after it said AstraZeneca Plc would make a $2 billion strategic equity investment in the cancer drugmaker to jointly develop drugs.
Read at Bloomberg →